Cholera toxin B subunit binding to an antigen-presenting cell directly costimulates cytokine production from a T cell clone

International Immunology

Volumn 8, Issue 12, 1996, Pages 1849-1856

  Li, Ta Kai ^a,b   Fox, Barbara S ^a,c  

^a UNIVERSITY OF MARYLAND   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c ImmuLogic Pharmaceutical Corporation   (United States)

Author keywords

Cholera toxin; Co stimulation; IL 4

Indexed keywords

CHOLERA TOXIN; CHOLERA TOXIN B SUBUNIT; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; IMMUNOSTIMULATION; LYMPHOCYTE CLONE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD3; CHOLERA TOXIN; CLONE CELLS; CYTOKINES; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PROTEIN BINDING; RATS; RATS, INBRED LEW; TH2 CELLS;

EID: 0030444083     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.12.1849     Document Type: Article

References (34)

1. Lycke, N. and Holmgren, J. 1986. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59:301.
2. Chen, K.-S. and Strober, W. 1990. Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response. Eur. J. Immunol. 20:433.
3. Clarke, C. J., Wilson, A. D., Williams, N. A. and Strokes, C. R. 1991. Mucosal priming of T-lymphocyte responses to fed protein antigens using cholera toxin as an adjuvant. Immunology 72:323.
4. Xu-Amano, J., Kiyono, H., Jackson, R. J., Staats, H. F., Fujihashi, K., Burrows, P. D., Elson, C. O., Pillai, S. and McGhee, J. R. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:1309.
5. Jackson, R. J., Fujihashi, K., Xu-Amano, J., Kiyono, H., Elson, C. O. and McGhee, J. R. 1993. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immun. 61:4272.
6. Liang, X., Lamm, M. E. and Nedrud, J. G. 1988. Oral administration of cholera toxin-sendai virus conjugate potentiates gut and respiratory immunity against sendai virus. J. Immunol. 141:1495.
7. Kammer, G. M. 1988. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 9:222
8. Fishman, P. H. 1982. Role of membrane gangliosides in the binding and action of bacterial toxins. J. Membrane Biol. 69:85.
9. Lycke, N., Tsuji, T. and Holmgren, J. 1992. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 22:2277.
10. Sun, J.-B., Holmgren, J. and Czerkinsky, C. 1994. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl Acad. Sci. USA 91:10795.
11. Snider, D. P., Marshall, J. S., Perdue, M. H. and Liang, H. 1994. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J. Immunol. 153:647.
12. Hirabayashi, Y., Tamura, S. I., Shimada, K. and Kurata, T. 1992. Involvement of antigen-presenting cells in the enhancement of the in vitro antibody responses by cholera toxin B subunit. Immunology 75:493.
13. Lycke, N. Y. 1993. Cholera toxin promotes B cell isotype switching by two different mechanisms: cAMP induction augments germline Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation. J. Immunol. 150:4810.
14. M1 induces B cell activation. J. Immunol. 148:1999.
15. Campbell, K. S. and Munson, A. E. 1987. Potentiation of the in vitroT-dependent antibody response by the B subunit of cholera toxin. J. Pharmacol. Exp. Ther. 242:895.
16. Tamura, S.-I., Samegai, Y., Kurata, H., Kikuta, K., Nagamine, T., Aizawa, C, and Kurata, T. 1989. Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine. Vaccine 7:257.
17. Yankelevich, B., Brown, E. and Mazumder, A. 1995. Prevention of acute graft-versus-host disease by treatment with a novel immunosuppressant: cholera toxin B subunit. J. Immunol. 154:3611.
18. Elson, C. O., Holland, S. P., Dertzbaugh, M. T., Cuff, C. F. and Anderson, A. O. 1995. Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. J. Immunol. 154:1032.
19. Woogen, S. D., Ealding, W. and Elson, C. O. 1987. Inhibition of murine lymphocyte proliferation by the B subunit of cholera toxin. J. Immunol. 139:3764.
20. Vadolas, J., Davies, J. K., Wright, P. J. and Strugnell, R. A. 1995. Intranasal immunization with liposomes induces strong mucosal immune responses in mice. Eur. J. Immunol. 25:969.
21. Leo, O., Foo, M., Sachs, D. H., Samelson, L. E. and Bluestone, J. A. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl Acad. Sci. USA 84:1374.
22. Ohara, J. and Paul, W. E. 1985. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315:333.
23. Nussenzweig, M. C., Steinman, R. M., Witmer, M. D. and Gutchinov, B. 1982. A monoclonal antibody specific for mouse dendritic cells. Proc. Natl Acad. Sci. USA 79:161.
24. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. and Coffman, R. L. 1986. Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
25. 2. J. Immunol. 150:1680.
26. + B cell hybridomas to H-2-restricted T cell hybridomas. Proc. Natl Acad. Sci. USA 79:3604.
27. Fox, B. S. 1993. Antigen presenting cell-derived co-stimulatory signals can selectively regulate IL-2 and IL-4 production from a Th0 cell hybridoma. Int. Immunol. 5:323.
28. Kearney, J. F., Radbruch, A., Liesegang, B. and Rajewsky, K. 1979 A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J. Immunol. 123:1248.
29. Hu-Li, J., Ohara, J., Watson, C., Tsang, W. and Paul, W. E. 1989. Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J. Immunol. 142:800.
30. Klausner, R. D., O'Shea, J. J., Luong, H., Ross, P., Bluestone, J. A. and Samelson, L. E. 1987. T cell receptor tyrosine phosphorylation: variable coupling for different activating ligands. J. Biol. Chem. 262:12654.
31. Liu, Y. and Janeway, C. A. J. 1992. Cells that present both specific ligand and co-stimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. Proc. Natl Acad. Sci. USA 89:3845.
32. Sixma, T. K., Pronk, S. E., Kalk, K. H., Wartna, E. S., van Zanten, B. A. M., Witholt, B. and Hol, W. G. J. 1991. Crystal structure of a cholera toxin-related heat-labile enterotoxin from F. coli. Nature 351:371.
33. Morita, A., Tsao, D. and Kim, Y. S. 1980. Identification of cholera toxin binding glycoproteins in rat intestinal microvillus membranes. J. Biol. Chem. 255:2549.
34. m1-neoganglioproteins are non-functional receptors for cholera toxin. J. Biol. Chem. 265:7673.